Severe hyperlipidemia initially was discovered in pregnancy with pancreatitis.

A pre-existing genetic defect compromising lipid metabolism was evaluated.

The recurrent AP in the patient was attributable to a novel compound heterozygous mutations in LPL.

The mutations are responsible for markedly reduced LPL activity in postheparin plasma.